共 16 条
[1]
BANNER W, 1986, PEDIATR CLIN N AM, V33, P393
[2]
ELLENHORN MJ, 1988, MED TOXICOLOGY DIAGN, P1023
[3]
FREEMAN DA, 1981, VET HUM TOXICOL, V23, P351
[4]
Henretig F M, 1984, Emerg Med Clin North Am, V2, P121
[5]
Herbert V., 1975, PHARMACOL BASIS THER, P1309
[7]
IRON-CHELATING THERAPY
[J].
CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES,
1988, 26 (04)
:303-345
[8]
KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758
[9]
ACUTE CHANGES IN RENAL-FUNCTION ASSOCIATED WITH DEFEROXAMINE THERAPY
[J].
AMERICAN JOURNAL OF DISEASES OF CHILDREN,
1989, 143 (09)
:1077-1080
[10]
DETERMINATION OF DESFEROXAMINE AND A MAJOR METABOLITE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - APPLICATION TO THE TREATMENT OF ALUMINUM-RELATED DISORDERS
[J].
JOURNAL OF CHROMATOGRAPHY,
1985, 341 (01)
:123-130